logo

For the Inventor, By the Inventor

Toronto, Canada

Johanna Rommens

This inventor holds 39 USPTO granted patents and 2 published patent applications and 1 EPO patent, primarily in Genetic Research. Top assignees: The Hospital for Sick Children, Hsc Research and Development Limited Partnership, University of California. Active years: 1996-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Johanna Rommens. Retrieved from https://idiyas.com/inventor/johanna-rommens

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 39 

% Patents Active = 82.1


Average Co-Inventor Count = 3.8

ph-index = 10

Forward Citations = 342(Granted Patents)


Location History:

  • Willowdale, CA (1996 - 2006)
  • Ontario, CA (2010)
  • Toronto, CA (1998 - 2022)

Company Filing History:

goldMedal11 out of 167 
 
The Hospital for Sick Children
 patents
silverMedal10 out of 36 
 
Hsc Research and Development Limited Partnership
 patents
bronzeMedal7 out of 16,035 
 
University of California
 patents
4. 7 out of 532 
 
University of Toronto
 patents
5. 5 out of 15 
 
Hsc Research Development Corporation
 patents
6. 4 out of 123 
 
Myriad Genetics, Inc.
 patents
7. 3 out of 80 
 
Endorecherche, Inc.
 patents
8. 2 out of 3,543 
 
University of Michigan
 patents
9. 2 out of 2,659 
 
University of Pennsylvania
 patents
10. 1 out of 1 
 
Hsc Reseach & Development Limited Partnership
 patent
11. 1 out of 1 
 
Hsc Research & Development Limited Parntership
 patent
12. 1 out of 5 
 
Hsc Research and Development Limited
 patents
13. 1 out of 1 
 
Research and Development Limited Partnership
 patent
14. 1 out of 8 
 
The Board of Regents Acting for and on Behalf of the University of
 patents
15. 1 out of 1 
 
The Hospital for Sick Children, Hsc Research and Development Limited
 patent
16. 1 out of 963 
 
The University of British Columbia
 patents
17. 1 out of 1 
 
Trustees of the University of Pennsylvaina
 patent
18. 1 out of 1,687 
 
University of Utah Research Foundation
 patents
19. 9 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1996-2022

Loading Chart...
Loading Chart...
Areas of Expertise:
Cystic Fibrosis Gene
Presenilin Mutations
Alzheimer's Disease
Breast Cancer Susceptibility
Genetic Sequences
Diagnosis Methods
Transgenic Mice
Cancer Genetics
Nucleic Acids
Mutant Proteins
Gene Therapy
Genomic Diagnostics
39 patents (USPTO):Explore Patents
1. 11510907 - Modifiers of CFTR-directed therapy (2022-11-29),
2. 8993251 - Genes from 20q13 amplicon and their uses (2015-03-31),
3. 8101370 - Genes from the 20q13 amplicon and their uses (2012-01-24),
4. 7846679 - Methods for detecting the presence of mutant mammalian presenilin protein (2010-12-07),
5. 7838247 - Antibody specific for mutant presenilin 2 and method of use thereof (2010-11-23),
6. 7811986 - Genes from the 20Q13 amplicon and their uses (2010-10-12),
7. 7785777 - Diagnosis of Shwachman-Diamond Syndrome (2010-08-31),
8. 7507798 - Antibody specific for mutant presenilin 1 (2009-03-24),
9. 7455964 - Genes from the 20q13 amplicon and their uses (2008-11-25),
10. 7413899 - Genes from the 20q13 amplicon and their uses (2008-08-19),
11. 7049424 - Genes from the 20Q13 amplicon and their uses (2006-05-23),
12. 6998467 - Antibody specific for presenilin 1 and method of use thereof (2006-02-14),
13. 6984487 - Cystic fibrosis gene (2006-01-10),
14. 6902907 - Cystic fibrosis gene (2005-06-07),
15. 6844189 - Chromosome 17P-linked prostate cancer susceptibility gene (2005-01-18),

Title: The Innovative Work of Inventor Johanna Rommens

Introduction:

Johanna Rommens is a renowned inventor based in Toronto, CA, known for her pioneering work in the field of genetic modifications associated with various diseases. With a total of 19 patents to her name, Rommens has significantly contributed to advancements in personalized medicine and treatment methodologies.

Latest Patents:

1. Modifiers of CFTR-directed therapy: Rommens' patent revolves around a genetic modifier of cystic fibrosis (CF), which can predict the effectiveness of CFTR-directed therapy. By identifying specific SNPs in non-coding regions of SLC26A9, correlations with CF lung disease severity and patient response to therapies like Ivacaftor have been established. This innovation provides a breakthrough in predicting treatment efficacy and patient selection for CFTR-directed therapeutics.

2. Genes from 20q13 amplicon and their uses: This patent focuses on cDNA sequences from a region on chromosome 20 linked to diseases. The identified sequences are instrumental in detecting chromosomal abnormalities associated with various disorders and offer potential for disease treatment.

Career Highlights:

Johanna Rommens has made significant contributions working at prestigious institutions such as The Hospital for Sick Children and the University of California. Her career highlights include groundbreaking research in genetic modifiers and disease-associated gene sequences, leading to the development of novel treatment methodologies for complex diseases.

Collaborations:

Throughout her career, Rommens has collaborated with esteemed professionals in the field, including Joe W Gray and Colin Conrad Collins. These collaborations have fostered innovative research endeavors and propelled advancements in the field of genetics and personalized medicine.

Conclusion:

Inventor Johanna Rommens' dedication to advancements in genetic modifiers and disease treatment strategies has left a lasting impact on the field of personalized medicine. Her patents and collaborations stand as a testament to her innovative spirit and commitment to improving healthcare outcomes for individuals affected by complex diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…